Bristol-Myers Squibb Co news

   Watch this stock
Showing stories 1 - 10 of about 151   

Articles published

BMY 58.80 +0.19 (0.32%)
price chart
Dan Nathan Sees Unusual Options Activity In Bristol-Myers Squibb Co
A trader bought 7,500 contracts of the November 55 puts for $0.49, which sets the breakeven for this trade at $54.51. The trade followed a purchase of 150,000 stocks, so Nathan sees it as a protection for a long stock position.
Bristol-Myers Squibb Company (BMY) Leading In Pre-Market Activity  TheStreet.com
OliPass Announces a Worldwide Discovery Alliance with Bristol-Myers Squibb ...  Businessweek
Related articles »  
Bristol-Myers Squibb Co's Third-Quarter Earnings Beat the Street
Bristol-Myers Squibb (NYSE: BMY ) posted its third-quarter earnings this morning before the bell, beating consensus on both earnings per share and revenue.
Can Bristol-Myers Squibb Co (NYSE:BMY) Get it Done?  Stock Traders Daily
UPDATE: Bristol-Myers Squibb Q3 Earnings Top Estimates  Benzinga
Related articles »  
Why Bristol-Myers Squibb Co. Leaped 15% Higher in October
What: Shares of big pharma giant Bristol-Myers Squibb (NYSE: BMY ) shot higher by 15% in October, according to data from S&P Capital IQ, after the company reported better than expected third-quarter earnings results and released favorable mid-stage ...
Bristol-Myers Squibb Stock Rating Reaffirmed by JPMorgan Chase & Co. (BMY)  Watch List News (press release)
Intraday Movers�Bristol-Myers Squibb Co (NYSE:BMY), Whirlpool Corporation ...  Techsonian (press release)
Related articles »  
Morgan Stanley Downgrades Bristol-Myers On Valuation
In a note out Thursday, analyst David Risinger of Morgan Stanley lowered his rating on Bristol-Myers Squibb Co (NYSE: BMY) from Overweight to Equal-Weight, but maintained his $60 price objective.
One Reason Bristol-Myers Squibb (BMY) Stock Is Down Today  TheStreet.com
Kenny says Bristol-Myers Squibb decision 'a vote of confidence'  Irish Times
Related articles »  
Technical Notes Covering Pharma Equities - AbbVie, Bristol-Myers Squibb ...
On Wednesday, shares in Bristol-Myers Squibb Co. recorded a trading volume of 4.62 million shares, lower than its three months average volume of 6.31 million shares.
Related articles »  
Thursday's Analyst Moves: Bristol-Myers Squibb Co, Broadcom Corporation ...
Before Thursday's opening bell, a number of big name dividend stocks were the subject of analyst moves. Below, we highlight the important analyst commentary for investors.
Related articles »  
Drug makers Need Rest- Bristol-Myers Squibb Co (NYSE:BMY), Zogenix, Inc ...
Bristol-Myers Squibb Co (NYSE:BMY) plunged -1.38% in last trading session after the firm declared that 16 abstracts for Orencia were undertake for presentation at the 2014 yearly meeting of the American College of Rheumatology scheduled from November ...
Market Update: Bristol-Myers Squibb Company (NYSE:BMY) - Portola, Bristol ...
Summary (NYSE:BMY): Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.
Stocks Closed Above Secure Line - Bristol-Myers Squibb Co (BMY ...  Techsonian (press release)
Volatile Stocks in List: Bristol-Myers Squibb Company (NYSE:BMY), Alibaba ...  Street Newswire (registration)
Related articles »  
Stock Disclosure: Bristol-Myers Squibb Company, SLM Corporation
Bristol-Myers Squibb Company (NYSE:BMY) and F-star Alpha announced that the companies, together with the F-star Alpha shareholders, have entered into an agreement that provides Bristol-Myers Squibb the exclusive option to acquire F-star Alpha and ...
Bristol-Myers Squibb Receives Consensus Rating of �Hold� from Brokerages ...  Mideast Time
Closing Bell Stocks to Watch: Eastman Chemical Co. (EMN), Bristol-Myers ...  WallStreet Scope
Related articles »  
Stocks in Focus- Bristol-Myers Squibb Co (NYSE:BMY), Novartis AG (ADR ...
AstraZeneca Plc and Bristol-Myers Squibb Co (NYSE:BMY) won an appeal of an 11 year old lawsuit in which they were suspect of paying kickbacks to a medical benefits management company in return for purchases and approvals of drugs they make.
Morning Buzz: Petroleo Brasileiro (NYSE:PBR-A), AstraZeneca (NYSE:AZN ...  WallStreet Scope
Related articles »